Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Herpes Zoste Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Herpes Zoste Drugmarket, defines the market attractiveness level of Herpes Zoste Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Herpes Zoste Drug industry, describes the types of Herpes Zoste Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Herpes Zoste Drug market and the development prospects and opportunities of Herpes Zoste Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Herpes Zoste Drug market in Chapter 13.
By Player:
Astellas Pharma Inc
NAL Pharmaceuticals Ltd
ContraVir Pharmaceuticals, Inc
ReceptoPharm, Inc
GlaxoSmithKline Plc
GeneOne Life Science, Inc
Foamix Pharmaceuticals Ltd
Merck & Co, Inc
TSRL, Inc
Epiphany Biosciences, Inc
Beijing Minhai Biotechnology Co, Ltd
By Type:
Acyclovir
Amenamevir
FV-100
GLS-5100
GSK-1437173A
NAL-3221
Others
By End-User:
Clinic
Hospital
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Herpes Zoste Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Herpes Zoste Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Herpes Zoste Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Herpes Zoste Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Herpes Zoste Drug Market Analysis and Outlook to 2022
-
7.1 Global Herpes Zoste Drug Consumption (2017-2022)
-
7.2 United States Herpes Zoste Drug Consumption (2017-2022)
-
7.3 Europe Herpes Zoste Drug Consumption (2017-2022)
-
7.4 China Herpes Zoste Drug Consumption (2017-2022)
-
7.5 Japan Herpes Zoste Drug Consumption (2017-2022)
-
7.6 India Herpes Zoste Drug Consumption (2017-2022)
-
7.7 South Korea Herpes Zoste Drug Consumption (2017-2022)
8 Region and Country-wise Herpes Zoste Drug Market Analysis and Outlook to 2028
-
8.1 Global Herpes Zoste Drug Consumption Forecast (2022-2028)
-
8.2 United States Herpes Zoste Drug Consumption Forecast (2022-2028)
-
8.3 Europe Herpes Zoste Drug Consumption Forecast (2022-2028)
-
8.4 China Herpes Zoste Drug Consumption Forecast (2022-2028)
-
8.5 Japan Herpes Zoste Drug Consumption Forecast (2022-2028)
-
8.6 India Herpes Zoste Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Herpes Zoste Drug Consumption Forecast (2022-2028)
9 Global Herpes Zoste Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Herpes Zoste Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Acyclovir Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Amenamevir Consumption and Growth Rate (2017-2022)
-
9.1.3 Global FV-100 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global GLS-5100 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global GSK-1437173A Consumption and Growth Rate (2017-2022)
-
9.1.6 Global NAL-3221 Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Herpes Zoste Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Herpes Zoste Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Herpes Zoste Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Acyclovir Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Amenamevir Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global FV-100 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global GLS-5100 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global GSK-1437173A Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global NAL-3221 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Herpes Zoste Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Herpes Zoste Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Herpes Zoste Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Herpes Zoste Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Herpes Zoste Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Herpes Zoste Drug Market Competitive Analysis
-
14.1 Astellas Pharma Inc
-
14.1.1 Astellas Pharma Inc Company Details
-
14.1.2 Astellas Pharma Inc Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Astellas Pharma Inc Herpes Zoste Drug Product and Service
-
14.2 NAL Pharmaceuticals Ltd
-
14.2.1 NAL Pharmaceuticals Ltd Company Details
-
14.2.2 NAL Pharmaceuticals Ltd Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 NAL Pharmaceuticals Ltd Herpes Zoste Drug Product and Service
-
14.3 ContraVir Pharmaceuticals, Inc
-
14.3.1 ContraVir Pharmaceuticals, Inc Company Details
-
14.3.2 ContraVir Pharmaceuticals, Inc Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 ContraVir Pharmaceuticals, Inc Herpes Zoste Drug Product and Service
-
14.4 ReceptoPharm, Inc
-
14.4.1 ReceptoPharm, Inc Company Details
-
14.4.2 ReceptoPharm, Inc Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 ReceptoPharm, Inc Herpes Zoste Drug Product and Service
-
14.5 GlaxoSmithKline Plc
-
14.5.1 GlaxoSmithKline Plc Company Details
-
14.5.2 GlaxoSmithKline Plc Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 GlaxoSmithKline Plc Herpes Zoste Drug Product and Service
-
14.6 GeneOne Life Science, Inc
-
14.6.1 GeneOne Life Science, Inc Company Details
-
14.6.2 GeneOne Life Science, Inc Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 GeneOne Life Science, Inc Herpes Zoste Drug Product and Service
-
14.7 Foamix Pharmaceuticals Ltd
-
14.7.1 Foamix Pharmaceuticals Ltd Company Details
-
14.7.2 Foamix Pharmaceuticals Ltd Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Foamix Pharmaceuticals Ltd Herpes Zoste Drug Product and Service
-
14.8 Merck & Co, Inc
-
14.8.1 Merck & Co, Inc Company Details
-
14.8.2 Merck & Co, Inc Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Merck & Co, Inc Herpes Zoste Drug Product and Service
-
14.9 TSRL, Inc
-
14.9.1 TSRL, Inc Company Details
-
14.9.2 TSRL, Inc Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 TSRL, Inc Herpes Zoste Drug Product and Service
-
14.10 Epiphany Biosciences, Inc
-
14.10.1 Epiphany Biosciences, Inc Company Details
-
14.10.2 Epiphany Biosciences, Inc Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Epiphany Biosciences, Inc Herpes Zoste Drug Product and Service
-
14.11 Beijing Minhai Biotechnology Co, Ltd
-
14.11.1 Beijing Minhai Biotechnology Co, Ltd Company Details
-
14.11.2 Beijing Minhai Biotechnology Co, Ltd Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Beijing Minhai Biotechnology Co, Ltd Herpes Zoste Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Herpes Zoste Drug
-
Figure Herpes Zoste Drug Picture
-
Table Global Herpes Zoste Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Herpes Zoste Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Herpes Zoste Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Herpes Zoste Drug Consumption by Country (2017-2022)
-
Figure United States Herpes Zoste Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Herpes Zoste Drug Consumption and Growth Rate (2017-2022)
-
Figure China Herpes Zoste Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Herpes Zoste Drug Consumption and Growth Rate (2017-2022)
-
Figure India Herpes Zoste Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Herpes Zoste Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Herpes Zoste Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Herpes Zoste Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Herpes Zoste Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Herpes Zoste Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Herpes Zoste Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Herpes Zoste Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Herpes Zoste Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acyclovir Consumption and Growth Rate (2017-2022)
-
Figure Global Amenamevir Consumption and Growth Rate (2017-2022)
-
Figure Global FV-100 Consumption and Growth Rate (2017-2022)
-
Figure Global GLS-5100 Consumption and Growth Rate (2017-2022)
-
Figure Global GSK-1437173A Consumption and Growth Rate (2017-2022)
-
Figure Global NAL-3221 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Acyclovir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Amenamevir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global FV-100 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GLS-5100 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GSK-1437173A Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NAL-3221 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Herpes Zoste Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Herpes Zoste Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Astellas Pharma Inc (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Inc Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Inc Herpes Zoste Drug Product and Service
-
Table NAL Pharmaceuticals Ltd (Foundation Year, Company Profile and etc.)
-
Table NAL Pharmaceuticals Ltd Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table NAL Pharmaceuticals Ltd Herpes Zoste Drug Product and Service
-
Table ContraVir Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table ContraVir Pharmaceuticals, Inc Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table ContraVir Pharmaceuticals, Inc Herpes Zoste Drug Product and Service
-
Table ReceptoPharm, Inc (Foundation Year, Company Profile and etc.)
-
Table ReceptoPharm, Inc Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table ReceptoPharm, Inc Herpes Zoste Drug Product and Service
-
Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Plc Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc Herpes Zoste Drug Product and Service
-
Table GeneOne Life Science, Inc (Foundation Year, Company Profile and etc.)
-
Table GeneOne Life Science, Inc Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GeneOne Life Science, Inc Herpes Zoste Drug Product and Service
-
Table Foamix Pharmaceuticals Ltd (Foundation Year, Company Profile and etc.)
-
Table Foamix Pharmaceuticals Ltd Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Foamix Pharmaceuticals Ltd Herpes Zoste Drug Product and Service
-
Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co, Inc Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co, Inc Herpes Zoste Drug Product and Service
-
Table TSRL, Inc (Foundation Year, Company Profile and etc.)
-
Table TSRL, Inc Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table TSRL, Inc Herpes Zoste Drug Product and Service
-
Table Epiphany Biosciences, Inc (Foundation Year, Company Profile and etc.)
-
Table Epiphany Biosciences, Inc Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Epiphany Biosciences, Inc Herpes Zoste Drug Product and Service
-
Table Beijing Minhai Biotechnology Co, Ltd (Foundation Year, Company Profile and etc.)
-
Table Beijing Minhai Biotechnology Co, Ltd Herpes Zoste Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beijing Minhai Biotechnology Co, Ltd Herpes Zoste Drug Product and Service
-
